Home | News Release Archive | News Blog | Features | In the News | RSSFeeds

Legacy of the Philadelphia Chromosome Discovery

The relationship between chromosome alterations and cancer had been debated for more than one hundred years. The first direct link between chromosomal abnormalities to any malignancy came with the discovery of the Philadelphia Chromosome in 1960 by Peter Nowell at the University of Pennsylvania School of Medicine and the late David Hungerford from the Fox Chase Cancer Center’s Institute for Cancer Research. Understanding abnormalities in the replication of the chromosome led to the eventual development of the genetically targeted cancer drug Gleevec in 2001, and others in the pipeline.

Commemorating the 50th anniversary of this discovery, in 2010, Dr. Nowell is being honored with the Franklin Institute’s Benjamin Franklin Medal in Life Science and an honorary doctor of science degree from Penn. Nowell is also a recipient of the Albert Lasker Award for Medical Research.

Philadelphia Chromosome: The Science

Philadelphia Chromosome: The History

Subscribe to this Site


In the News


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2016, The Trustees of the University of Pennsylvania